Abstract. It is well known that the category of real Lie supergroups is equivalent to the category of the so called (real) Harish-Chandra pairs, see [3,6,7]. That means that a Lie supergroup depends only on the underlying Lie group and its Lie superalgebra with certain compatibility conditions. More precisely, the structure sheaf of a Lie supergroup and the supergroup morphisms can be explicitly described in terms of the corresponding Lie superalgebra. In this paper, we give a proof of this result in the complexanalytic case. Furthermore, if (G, O G ) is a complex Lie supergroup and H ⊂ G is a closed Lie subgroup, i.e. it is a Lie subsupergroup of (G, O G ) and its odd dimension is zero, we show that the corresponding homogeneous supermanifold (G/H, O G/H ) is split. In particular, any complex Lie supergroup is a split supermanifold.It is well known that a complex homogeneous supermanifold may be nonsplit (see, e.g., [15]). We find here necessary and sufficient conditions for a complex homogeneous supermanifold to be split.
We prove that every orthogonal Gelfand-Zeitlin algebra U acts (faithfully) on its Gelfand-Zeitlin subalgebra Γ. Considering the dual module, we show that every Gelfand-Zeitlin character of Γ is realizable in a U -module. We observe that the Gelfand-Zeitlin formulae can be rewritten using divided difference operators. It turns out that the action of the latter operators on Γ gives rise to an explicit basis in a certain Gelfand-Zeitlin submodule of the dual module mentioned above. This gives, generically, both in the case of regular and singular Gelfand-Zeitlin characters, an explicit construction of simple modules which realize the given Gelfand-Zeitlin characters.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.